Sign In
Buy NKTR
$59.23
+0.670 (+1.14%)
At Close: Jun 03, 2026
Manche mögen´s heiß!
08:00am, Thursday, 25'th Jun 2020
DIE UMWELTBERATUNG stellt in einem neuen Poster robuste Pflanzen für die Zeiten des Klimawandels vor.
Erstaunlich viele Bienen-Arten in Zürich - Blick
07:13am, Wednesday, 24'th Jun 2020
Wer sagt denn, Grossstädte seien lebensfeindliche Biotope? Die Stadt Zürich jedenfalls verfügt über eine derartige Vielfalt an Wildbienen, die selbst Forscher überrascht: 164 der in der Schweiz h
Hedge Funds Aren’t Impressed By Nektar Therapeutics (NKTR)
01:46am, Wednesday, 24'th Jun 2020
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev
Maverick Capital Ltd. Raises Stock Holdings in Nektar Therapeutics (NASDAQ:NKTR)
07:44am, Tuesday, 23'rd Jun 2020
Maverick Capital Ltd. boosted its stake in Nektar Therapeutics (NASDAQ:NKTR) by 51.1% during the 1st quarter, Holdings Channel reports. The institutional investor owned 4,898,401 shares of the biophar
Brookfield Properties Is Suing Gap Over Missed Rent Payments | The Motley Fool
04:59pm, Monday, 22'nd Jun 2020
Retailer said it is negotiating with landlords over a "fair" rent to pay.
Thrivent Financial for Lutherans Has $2.30 Million Stock Holdings in Nektar Therapeutics (NASDAQ:NKTR)
09:35am, Monday, 22'nd Jun 2020
Thrivent Financial for Lutherans boosted its position in Nektar Therapeutics (NASDAQ:NKTR) by 179.7% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 128,589 shares
Canada Pension Plan Investment Board Takes $44,000 Position in Nektar Therapeutics (NASDAQ:NKTR)
07:20am, Friday, 19'th Jun 2020
Canada Pension Plan Investment Board acquired a new stake in Nektar Therapeutics (NASDAQ:NKTR) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and
Parametric Portfolio Associates LLC Reduces Stock Position in Nektar Therapeutics (NASDAQ:NKTR)
06:38am, Friday, 19'th Jun 2020
Parametric Portfolio Associates LLC trimmed its holdings in shares of Nektar Therapeutics (NASDAQ:NKTR) by 7.5% in the first quarter, according to its most recent filing with the Securities and Exchan
Innovations In Cancer Treatment That Could Render Chemotherapy Antiquated
10:27am, Thursday, 11'th Jun 2020
When thinking about the future of medicine, it often helps to look to the past. We believe that chemotherapy will one day be viewed as antiquated as lobotomies
Mizuho Securities Sticks to Their Buy Rating for Xeris Pharmaceuticals (XERS) - Markets
12:37pm, Sunday, 07'th Jun 2020
In a report issued on June 5, Difei Yang from Mizuho Securities maintained a Buy rating on Xeris Pharmaceuticals (XERS
Why Is Nektar (NKTR) Up 12% Since Last Earnings Report?
03:31pm, Saturday, 06'th Jun 2020
Nektar (NKTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Los índices de Estados Unidos cierran al alza; el Dow Jones Industrial Average avanza un 3,15%
12:00am, Friday, 05'th Jun 2020
Los índices de Estados Unidos cierran al alza; el Dow Jones Industrial Average avanza un 3,15%
SAN FRANCISCO, June 4, 2020 /PRNewswire via COMTEX/ --
SAN FRANCISCO, June 4, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) today announced the...
